Analeah Heidt
Plus aucun poste en cours
Profil
Analeah Heidt worked as an Executive Vice President-Translational Research at Inhibrx, Inc.
Anciens postes connus de Analeah Heidt
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 01/08/2021 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
